Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Respiratory Medicine

P3.16-10 Radiomic Features on CT Are Prognostic of Recurrence as Well as Predictive of Added Benefit of Adjuvant Chemotherapy in ES-NSCLC

Journal of Thoracic Oncology

English

Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non–Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor Receptor Mutation in Either Exon 19 or 21

Journal of Thoracic Oncology

English

P2.01-57 Prognostic Implication of Clinical, Imaging, and Pathologic Parameters in N2(+) Stage IIIA Lung Cancer Patients

Journal of Thoracic Oncology

English

PC01.04 CON in Mesothelioma Should Only Be Given on Clinical Trials

Journal of Thoracic Oncology

English

Bronchial Reactivity Indices Are Determinants of Health-Related Quality of Life in Patients With Stable Asthma

English

P2.13-41 a Novel Mitochondria-Based Targeting to Restore Therapeutic Response in Cisplatin- And Gefitinib-Resistant Human Lung Cancer Cells

Journal of Thoracic Oncology

English

P2.17-15 Mediastinoscopic Assessment of N2 Disease and Optimisation of Surgical Treatment of N2 Disease in NSCLC

Journal of Thoracic Oncology

English

P3.08-14 Long-Term Survival Following Surgical Resection of Isolated Brain Metastasis in Non-Small Cell Lung Cancer.

Journal of Thoracic Oncology

English

P1.01-17 Immune-Related Adverse Events in Patients With Metastatic Non-Small Cell Lung Cancer: Sex Differences and Response to Therapy

Journal of Thoracic Oncology

English

P3.16-21 Robotic Thoracic Surgery in Lung Cancer Resection – A Comprehensive Review

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Respiratory Medicine

P3.16-10 Radiomic Features on CT Are Prognostic of Recurrence as Well as Predictive of Added Benefit of Adjuvant Chemotherapy in ES-NSCLC

Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non–Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor Receptor Mutation in Either Exon 19 or 21

P2.01-57 Prognostic Implication of Clinical, Imaging, and Pathologic Parameters in N2(+) Stage IIIA Lung Cancer Patients

PC01.04 CON in Mesothelioma Should Only Be Given on Clinical Trials

Bronchial Reactivity Indices Are Determinants of Health-Related Quality of Life in Patients With Stable Asthma

P2.13-41 a Novel Mitochondria-Based Targeting to Restore Therapeutic Response in Cisplatin- And Gefitinib-Resistant Human Lung Cancer Cells

P2.17-15 Mediastinoscopic Assessment of N2 Disease and Optimisation of Surgical Treatment of N2 Disease in NSCLC

P3.08-14 Long-Term Survival Following Surgical Resection of Isolated Brain Metastasis in Non-Small Cell Lung Cancer.

P1.01-17 Immune-Related Adverse Events in Patients With Metastatic Non-Small Cell Lung Cancer: Sex Differences and Response to Therapy

P3.16-21 Robotic Thoracic Surgery in Lung Cancer Resection – A Comprehensive Review